GLP-1 boom feeds into side effects market

A new market is emerging as a result of the side effects caused by the popularity of weight-loss drugs like GLP-1 medications, such as Ozempic and Mounjaro. Radhika Ghai, founder of the premium cosmetics e-commerce platform Kindlife, explains that this is the biggest demand driver for the beauty industry in a decade and it's coming from a pharmacy, not a trend cycle.

When individuals lose weight rapidly, the medication not only depletes body fat but also reduces facial volume, skin elasticity, and hair, leading to a growing market for specific products. These include barrier repair, collagen-support skincare, and firming body care. What sets this market apart is that demand continues to grow as more patients start using GLP-1 drugs, unlike seasonal trends.

Rapid weight loss as a side effect of GLP-1 drugs not only causes a loss of body fat but also leads to a shortage of protein and fiber, which companies are rushing to fill with nutrition-dense foods and makeup products. Companies like Sugar Cosmetics, HUL's Lakme, and Nestle are stepping in to address this gap by offering non-invasive makeup alternatives, such as lip fillers, and nutrition supplements like Celevida GLP+ by Nestle Health Science and Dr. Reddy's Laboratories.

Additionally, Tata Consumer Products is preparing to enter the segment by introducing protein and fiber-rich waters and snacks to help consumers manage weight-loss side effects by supplementing their food intake.